AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE

Similar documents
NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

Pharmacist Learning Objectives

Naloxone Standing Order for Opioid Overdose

Opioid Harm Reduction

Opioid Overdose Education and Naloxone Distribution

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

Pennsylvania DEPARTMENT OF HEALTH

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

POWER TO HELP REVERSE AN OPIOID OVERDOSE

Welcome to the Opioid Overdose Prevention Project

Revised 16 February, of 7

Calvert County Health Department Overdose Education and Naloxone Training

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

Opiate Overdose Treatment: Naloxone Training Protocol

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Naloxone and Combating the Opioid Epidemic

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING

Naloxone in Schools. Training for School Staff

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Naloxone Administration Training

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Braintree Public Schools

Opioids and Overdose 2017

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

Reducing opioid overdose mortality: role of communityadministered

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

Prescription Drug Misuse/Abuse in Seniors. April Rovero Founder/Executive Director

Overdose Response Training

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic

Anyone Can Become Addicted. Anyone.

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT

First Responder Naloxone Grant Webinar

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including:

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

Sierra Sacramento Valley EMS Agency

IMPLEMENTATION OF A SHARED MEDICAL APPOINTMENT FOR OPIOID OVERDOSE EDUCATION AND NALOXONE KIT TRAINING FOR VETERANS Kristin A. Tallman, Pharm.

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction

Drug Class Review: Opioid Reversal Agents

HOW TO USE YOUR INSTANYL SINGLE-DOSE NASAL SPRAY

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

Using your Take Home Naloxone Kit

Opioids - Fentanyl - Naloxone. Public Health Nurse

Protocol For: Personally Furnishing Naloxone. Update Log

HOW TO USE YOUR INSTANYL MULTI-DOSE NASAL SPRAY

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

Opioids drive continued increase in drug overdose deaths

Dosage. Hospira Mylan Amphastar Amphastar syringe Teleflex (nasal adapter) 0.4 mg/ml 4 mg/10 ml. 1mg/mL (2mg/2mL) Nov (b)(2) Narcan Nasal

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

Pharmacist Directed Opioid Antagonist Dispensing

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Background. Epidemiology 8/28/2018

Naloxone for opioid safety

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA

Opioid Use Disorders &Medication Treatment

The Use of Naloxone in Workers Compensation. A Workers Compensation Continuing Education Course

A Bill Regular Session, 2015 SENATE BILL 880

Strategies to Manage The Opioid Crisis

Opioid Safety: Focus on Furnishing Naloxone

Naloxone for Opioid Overdose (FAQs)

BROCKTON AREA S OPIOID OVERDOSE PREVENTION TRAINING

``Considerations for using opioid drug therapy in workers compensation include patient safety, drug effectiveness and financial impacts

Let s Talk About. Pain Medicines. wisconsin. health literacy. A division of Wisconsin Literacy, Inc.

Prescription Opioids

Prevention and Harm Reduction Collaborating to Address Opioid-Related Overdose

Talking with your doctor

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Naloxone for Opioid Overdose (FAQs)

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Training of Trainers Maryland Overdose Response Program

MEDICATION ASSISTED TREATMENT

DECEMBER 7, 2017 THE OPIOID EPIDEMIC & THE UNIVERSITY S RESPONSE

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES

Substance Misuse and Abuse

Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum)

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

<ctrl> <click> Here to the start the sound.

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

The Prescription Opioid and Heroin Crisis

HEALTHCARE AND THE OPIOID EPIDEMIC DAN MUSE, MD SIGNATURE HEALTHCARE-BROCKTON HOSPITAL

Steve Alsum. The Grand Rapids Red Project. (616)

Transcription:

AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE Jasmine Carpenter, Pharm. D, BCPS, BCPP Clinical Pharmacy Specialist-PACT Mental Health Veterans Affairs Medical Center, Washington DC

OBJECTIVES Review and discuss the epidemiology of opioid overdose in the United States Explain the pharmacology of opioids and how these aspects contribute and affect the presentation of opioid overdose Identify the signs, symptoms, and risks factors for opioid overdose and its associated complications Explain the pharmacology, pharmacokinetics and available formulations of naloxone Demonstrate the use of a naloxone delivery device in the event of an opioid overdose 2

AUDIENCE QUESTION Why is it important for pharmacists to be educated on opioid overdose? 3

RAPPER REFERENCES High-Dose Drug Interaction Drug Diversion Pop a Perky just to start up (pop it, pot it pop it) Pop two cups of purple just to warm up (two cups, drank) Auntie Greta serve ya perkys Migos-Slippery Poppin Pills is all we know Travis Scott-Antidote Opioid Misuse Drug Interaction I got Xanax, Percocet, Promethazine with Codeine Lil Wayne ft. 2 Chainz- Rich 4

CELEBRITIES WHO HAVE DIED FROM PAINKILLERS AND HEROIN Janis Joplin Heroin Overdose Year: 1970 Age: 27 Elvis Presley Multiple Rx drugs (Codeine) Year: 1977 Age: 42 Heath Ledger Oxycodone, hydrocodone, alprazolam and diazepam Year: 2008 Age: 28 Philip Seymour Hoffman Heroin & BZDs Year:2014 Age 46 Prince Fentanyl Year: 2016 Age: 57 Cnn: Celebrities who died from painkillers and heroin 5

THE EPIDEMIOLOGY 6

OPIOID OVERDOSE IN THE US Drug overdose is the leading cause of accidental deaths in the United States, being greater than car accidents and homicide The majority of these deaths involve an opioid (6 out of 10) From 2000-2015, more than half a million people died from drug overdoses 91 Americans die every day from an opioid overdose CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. Available at http://wonder.cdc.gov. 7

Is this epidemic only showing an increase in prescription opioids? 8

NATIONAL OPIOID OVERDOSE EPIDEMIC One recent study found that 4 in 5 new heroin users started out misusing prescription painkillers The number of Americans who have used heroin in the past year has steadily increased from 2002 to 2014 As a consequence the rate of heroin overdose nearly quadrupled from 2000 to 2013 Hedegaard MD MSPH, Chen MS PhD, Warner PhD. Drug-Poisoning Deaths Involving Heroin: United States, 2000-2013. National Center for Health Statistics Data Brief. 2015:190:1-8 9

OPIOID PHARMACOLOGY Opioids exerts their action by binding to 3 opioid receptors: Mu Delta Kappa Opioids cause respiratory depression via activation of the mu-receptor Opioids have a narrow therapeutic index With respiratory depression as the most serious toxic effect that can lead to fatality 10

RISK FACTORS FOR OPIOID OVERDOSE Taking more than prescribed Taking high dose opioids and long acting opioids 100 mg or more daily (morphine equivalent) Comorbid compromising medical conditions COPD Sleep Apnea Severe Pulmonary Conditions Taking the opioid with interacting medications Benzodiazepines Alcohol Other opioids Loss of Tolerance After hospitalization/rehabilitation/jail Medication Non-Adherence 11

SIGNS AND SYMPTOMS OF OPIOID OVERDOSE Loss of consciousness/ The patient cannot be awakened from sleep or heavy nodding Blue fingernails or lips /pale skin Very slow or no breathing Very slow or no heartbeat Vomiting/gurgling noises 12

POP QUIZ How did Jesse s girlfriend die on Breaking Bad? a) From breast cancer b) From an opioid overdose c) From a car accident d) From a heart attack 13

NALOXONE 14

WHY NALOXONE? Studies are proving that naloxone distribution is effective in decreasing the amount of overdose related deaths A 24-46 % decrease in opioid overdose was observed in communities that distributed naloxone devices 17 Naloxone distribution would prevent 6.5% of all overdose deaths for every 20% of heroin users reached by a distribution program 18 Prevention of 2,000 overdose deaths in a population of 200,000 heroin users 18 Walley A, Xuan Z, Hackman H et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:174-f174. Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1-9 15

TREATING OPIOID OVERDOSE Opioid overdoses, if caught on time, can be treated with a medication called Naloxone (Narcan ) Naloxone is an antidote for opioid overdose It knocks off the offending opioid and blocks the receptor Reverses respiratory depression 16

NALOXONE (NARCAN ) It possesses a strong affinity for the muopioid receptor Displaces the offending opioid and reversing it s central and peripheral effects Has a short half-life and the duration ranges from 20-90 minutes Routes of Administration: Intravenous (preferred)- ~2 minutes Intramuscular 2 to 5 minutes Subcutaneous 5 minutes Intranasal 8 to 13 minutes 17

Naloxone Intranasal Rescue Kit Non-FDA Approved Assembly Required Naloxone Auto-injector (Evzio) Naloxone Delivery Devices FDA Approved Provides Voice Instructions No Assembly Required Narcan Nasal Spray Each kit comes with a total of 2 doses FDA Approved No Assembly Required 18

NALOXONE DELIVERY DEVICES Evzio (Auto-Injector) Narcan Nasal Spray Intranasal Naloxone Rescue Kit FDA Approved FDA Approved Not FDA Approved Intramuscular or Subcutaneous Administration Intranasal Intranasal 90.5% successful use without training & 100% successful use with training 90.5% successful use without training 0% successful use without training & 57.1% successful use with training 19

DEVICES 5-7 COST OF NALOXONE DELIVERY Evzio Narcan Nasal Spray Intranasal Naloxone Kit $3750 per 2 auto-injectors $125 per dual package $37 per device for group purchasers such as law enforcement, fire fighters, collages ~$50 20

RESPONSE TO OPIOID OVERDOSE 1 Lightly shake the person and yell their name 2 Give 1st dose of Naloxone The proper response in the event of an Opioid Overdose 3 Call 911- ALWAYS 4 Open the airways and give 1 breath every 5 seconds 5 Consider naloxone again if: The patient does not start breathing in 2-3 minutes The patient responds to the first dose and then stops breathing again 6 Place the patient on his/her side to prevent choking

NALOXONE AUTO-INJECTOR: EVZIO 1 2 3 4 Pull the auto-injector from the outer case Pull firmly to remove the red safety guard Place the black end against the middle of the outer thigh, through clothing if necessary, then press firmly and hold in place for 5 seconds If no reaction in 2-3 minutes or if the person stops breathing again, give the second dose 22

NALOXONE NASAL SPRAY: NARCAN 1 2 3 4 5 Remove naloxone nasal spray from the box & peel back the tab with the circle to open the naloxone nasal spray Hold the naloxone nasal spray with thumb on the bottom of the plunger and your first and middle finger on either side of the nozzle Do NOT PRIME OR TEST the spray device. Tilt the person s head back and provide support under the neck with your hand. Gently insert the tip of the nozzle into one nostril until your fingers on either side of the nozzle are against the bottom of the person s nose Press the plunger firmly to give the entire dose of naloxone nasal spray. Remove the naloxone nasal spray from the nostril after giving the dose If no reaction in 2-3 minutes or if the person stops breathing again, give the second dose of naloxone in the other nostril using a new naloxone spray 23

DEMONSTRATION TIME!!!! 24

NALOXONE ADVERSE REACTIONS When naloxone is given, the patient may experience precipitated opioid withdrawal Nausea/vomiting Diarrhea Tachycardia Hypertension Anxiety Mydriais (enlarged pupils) Rhinorrhea (runny nose) Muscle spasms Diaphoresis (sweating) Gooseflesh Lacrimation/Yawning Bone and muscle pain 25

STEPWISE APPROACH TO COUNSELING PATIENTS ON NALOXONE 1 2 3 4 5 Discuss the risk factors for Opioid Overdose Outline the signs and symptoms of Opioid Overdose Discuss how to Respond to an Opioid Overdose Review the assembly and administration of Naloxone Document counseling 26

WHAT ROLE CAN I PLAY AS A PHARMACIST? Identify patients who are at high risk for an opioid overdose Provided counseling on opioid overdose Risk Factors Clinical presentation Provide counseling on the use of naloxone in the event of an opioid overdose 27

COMMON PATIENT COMPLAINTS I have been on these medications for years, I am not at risk for an opioid overdose I take my medications as prescribed. Does my doctor think that I am abusing my pain medications? You are making me feel like I am a junkie. This is another excuses for my doctor not to give me my pain medications. Having naloxone would be a trigger for me to relapse 28

CONCLUSION The rates of opioid overdose within the United States has drastically increased over the past decade Naloxone distribution in the community can helpful in decreasing the prevalence of opioid overdose deaths Pharmacists can play a major role in providing education on the risk factors and signs and symptoms of opioid overdose and the administration of naloxone in the event of an opioid overdose 29

QUESTIONS?? 30

REFERENCES 1. CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. Available at http://wonder.cdc.gov. 2. Hedegaard MD MSPH, Chen MS PhD, Warner PhD. Drug-Poisoning Deaths Involving Heroin: United States, 2000-2013. National Center for Health Statistics Data Brief. 2015:190:1-8 3. Walley A, Xuan Z, Hackman H et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:174-f174. 4. Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1-9 5. Thomson Reuters Micromedex Clinical Evidence Solutions. Thomson Reuters; c2011. RED BOOK Drug References; 2016. http://thomsonreuters.com/products_services/healthcare/healthcare_products/clinical_deci_support/micromedex_clinical_evidence_sols/med_ safety_solutions/red_book/. Accessed May 25, 2016. 6. Therapeutic Research Center. PL detail-document #320537, naloxone for opioid overdose (FAQs). Pharmacist s Letter/Prescriber s Letter. 2016;May:1-10. 7. College of Psychiatric & Neurologic Pharmacists. Pharmacy basics. Prescribe to Prevent website. http://prescribetoprevent.org/pharmacists/pharmacy-basics/. Published 2015. Updated February 2015. Accessed June 2, 2016. 8. Adapt Pharma facilitates Narcan (naloxone hydrochloride) nasal spray access to state and local public entities [news release]. Dublin, Ireland: Adapt Pharma; January 14, 2016. http://adaptpharma.com/adapt_press_release/january-14-2016/. Accessed May 25, 2016. 31

AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE Jasmine Carpenter, Pharm. D, BCPS, BCPP Clinical Pharmacy Specialist-PACT Mental Health Veterans Affairs Medical Center, Washington DC